4.7 Article

Echinochrome A Prevents Diabetic Nephropathy by Inhibiting the PKC-Iota Pathway and Enhancing Renal Mitochondrial Function in db/db Mice

期刊

MARINE DRUGS
卷 21, 期 4, 页码 -

出版社

MDPI
DOI: 10.3390/md21040222

关键词

echinochrome A; diabetic nephropathy; protein kinase C; renal fibrosis; oxidative stress

向作者/读者索取更多资源

Echinochrome A (EchA), a natural bioproduct from sea urchins, has antioxidant, anti-inflammatory, and antimicrobial effects. This study investigated its effects on diabetic nephropathy (DN) using mouse models. The results showed that EchA improved glucose tolerance, reduced biomarkers of kidney damage, decreased oxidative stress, and ameliorated renal fibrosis. Mechanistically, EchA inhibited specific signaling pathways involved in oxidative stress and fibrosis, while enhancing mitochondrial function and antioxidant activity. These findings suggest that EchA may be a therapeutic option for DN.
Echinochrome A (EchA) is a natural bioproduct extracted from sea urchins, and is an active component of the clinical drug, Histochrome((R)). EchA has antioxidant, anti-inflammatory, and antimicrobial effects. However, its effects on diabetic nephropathy (DN) remain poorly understood. In the present study, seven-week-old diabetic and obese db/db mice were injected with Histochrome (0.3 mL/kg/day; EchA equivalent of 3 mg/kg/day) intraperitoneally for 12 weeks, while db/db control mice and wild-type (WT) mice received an equal amount of sterile 0.9% saline. EchA improved glucose tolerance and reduced blood urea nitrogen (BUN) and serum creatinine levels but did not affect body weight. In addition, EchA decreased renal malondialdehyde (MDA) and lipid hydroperoxide levels, and increased ATP production. Histologically, EchA treatment ameliorated renal fibrosis. Mechanistically, EchA suppressed oxidative stress and fibrosis by inhibiting protein kinase C-iota (PKC iota)/p38 mitogen-activated protein kinase (MAPK), downregulating p53 and c-Jun phosphorylation, attenuating NADPH oxidase 4 (NOX4), and transforming growth factor-beta 1 (TGF beta 1) signaling. Moreover, EchA enhanced AMPK phosphorylation and nuclear factor erythroid2-related factor 2 (NRF2)/heme oxygenase 1 (HO-1) signaling, improving mitochondrial function and antioxidant activity. Collectively, these findings demonstrate that EchA prevents DN by inhibiting PKC iota/p38 MAPK and upregulating the AMPK alpha/NRF2/HO-1 signaling pathways in db/db mice, and may provide a therapeutic option for DN.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据